Business Context and Reporting Period
This Form 8-K Current Report was filed by Tivic Health Systems, Inc. (not Valion Bio, Inc.) on October 15, 2025, covering events occurring on October 8, 2025. The company is incorporated in Delaware and trades on The Nasdaq Stock Market under the symbol TIVC. The filing primarily addresses the execution of a new executive employment agreement.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial figures disclosed relate to executive compensation:
- Base Salary: $325,000 per annum for the Chief Executive Officer.
- Incentive Bonus: Up to 50% of base salary, at the Board's discretion.
- Severance: 12 months of base salary (1/12 per month) payable upon termination without cause or for good reason.
- Benefits: 12 months of COBRA coverage and continued equity vesting for 12 months under specific termination scenarios.
Material Changes
The material change reported is the replacement of the previous executive offer letter dated July 31, 2021, with a new formal Employment Agreement for CEO Jennifer Ernst. This agreement formalizes compensation terms, bonus eligibility, and severance provisions, replacing the prior arrangement.
Guidance, Outlook, and Risks
The filing contains no financial guidance, market outlook, or discussion of operational risks. The employment agreement specifies that employment is "at will," allowing termination by either party at any time. Separation benefits are contingent on the reason for termination; no benefits are provided if the CEO resigns without "good reason," is terminated for "cause," or dies or becomes disabled.
Investor Verification Checklist
- Verify the correct registrant name is Tivic Health Systems, Inc. (TIVC), as the input metadata incorrectly referenced Valion Bio, Inc.
- Review the full text of the Executive Employment Agreement (Exhibit 10.1) for specific definitions of "good reason" and "cause."
- Confirm the status of the Company's 2021 Equity Incentive Plan to understand the terms of the "annual focal grants" mentioned.
- Check subsequent filings for any financial updates, as this 8-K contains no financial statements.